Stichting European Myeloma Network
Clinical trials sponsored by Stichting European Myeloma Network, explained in plain language.
-
CAR-T therapy challenges standard transplant in major myeloma trial
Disease control OngoingThis large study aims to determine if a newer personalized cell therapy (CAR-T) works better than the current standard stem cell transplant for people newly diagnosed with multiple myeloma. About 750 participants will receive initial chemotherapy, then be randomly assigned to rec…
Phase: PHASE3 • Sponsor: Stichting European Myeloma Network • Aim: Disease control
Last updated Apr 02, 2026 14:58 UTC
-
Four-Drug attack on blood cancer shows promise in major trial
Disease control OngoingThis study is testing whether adding a drug called daratumumab to a standard three-drug combination works better for people newly diagnosed with multiple myeloma, a cancer of plasma cells in the bone marrow. It will involve about 709 participants who are eligible for a stem cell …
Phase: PHASE3 • Sponsor: Stichting European Myeloma Network • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC